Mizuho Maintains Buy on American Homes 4 Rent, Lowers Price Target to $33
Mizuho analyst Haendel St. Juste maintains American Homes 4 Rent (NYSE:AMH) with a Buy and lowers the price target from $35 to $33.
Goldman Sachs Downgrades Altimmune to Neutral, Lowers Price Target to $6
Goldman Sachs analyst Corinne Jenkins downgrades Altimmune (NASDAQ:ALT) from Buy to Neutral and lowers the price target from $20 to $6.
Amazon’s Second Round Of Downsizing Likely To Drive Margins, Analyst Says
Citi analyst Ronald Josey upgrades the rating on Amazon.Com, Inc (NASDAQ:AMZN) to Buy with a $145 price target. Earlier today, Amazon shared plans…
Thanks Crypto Rally: Marathon Digital May Run 47% Now, Says Gianni Di Poce
After a tough start to the year for Marathon Digital Holdings Inc (NASDAQ: MARA) shares, the crypto mining company stock is looking at a potential turnaround in the coming months.
Calvin Klein Owner PVH Has Strong Brand Health & Ability To Drive Margin Expansion, Says Analyst
Telsey Advisory Group analyst Dana Telsey reiterated an Outperform rating on the shares of PVH Corp (NYSE:PVH) with a price target of…
Argus Research Maintains Buy on FedEx, Raises Price Target to $240
Argus Research analyst John Eade maintains FedEx (NYSE:FDX) with a Buy and raises the price target from $200 to $240.
JMP Securities Reiterates Market Outperform on W.P. Carey, Maintains $86 Price Target
JMP Securities analyst Mitchell Germain reiterates W.P. Carey (NYSE:WPC) with a Market Outperform and maintains $86 price target.
Stephens & Co. Reiterates Overweight on Akoya Biosciences, Maintains $16 Price Target
Stephens & Co. analyst Mason Carrico reiterates Akoya Biosciences (NASDAQ:AKYA) with a Overweight and maintains $16 price target.
Wells Fargo Maintains Underweight on Molina Healthcare, Lowers Price Target to $282
Wells Fargo analyst Stephen Baxter maintains Molina Healthcare (NYSE:MOH) with a Underweight and lowers the price target from $307 to $282.
Needham Maintains Buy on Stagwell, Lowers Price Target to $8
Needham analyst Laura Martin maintains Stagwell (NASDAQ:STGW) with a Buy and lowers the price target from $9 to $8.